These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 12072155

  • 1. Expression of dopamine receptors and transporter in neuroendocrine gastrointestinal tumor cells.
    Lemmer K, Ahnert-Hilger G, Höpfner M, Hoegerle S, Faiss S, Grabowski P, Jockers-Scherübl M, Riecken EO, Zeitz M, Scherübl H.
    Life Sci; 2002 Jun 28; 71(6):667-78. PubMed ID: 12072155
    [Abstract] [Full Text] [Related]

  • 2. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
    Santanavanich C, Ebadi M, Govitrapong P.
    J Pineal Res; 2005 Apr 28; 38(3):170-5. PubMed ID: 15725338
    [Abstract] [Full Text] [Related]

  • 3. Determination of D1 and D2 dopamine receptor expression by Ntera-2 cells.
    Sakolsky DJ, Ashby B.
    Brain Res Mol Brain Res; 2000 Dec 08; 84(1-2):158-61. PubMed ID: 11113544
    [Abstract] [Full Text] [Related]

  • 4. Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function.
    Huang Y, Qiu AW, Peng YP, Liu Y, Huang HW, Qiu YH.
    Neuro Endocrinol Lett; 2010 Dec 08; 31(6):782-91. PubMed ID: 21196914
    [Abstract] [Full Text] [Related]

  • 5. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK, Senogles SE.
    J Neurochem; 1996 Jan 08; 66(1):222-32. PubMed ID: 8522958
    [Abstract] [Full Text] [Related]

  • 6. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors.
    Andringa G, Drukarch B, Leysen JE, Cools AR, Stoof JC.
    Eur J Pharmacol; 1999 Jan 01; 364(1):33-41. PubMed ID: 9920182
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regulation of human D1 dopamine receptor function and gene expression in SK-N-MC neuroblastoma cells.
    Sidhu A, Olde B, Humblot N, Kimura K, Gardner N.
    Neuroscience; 1999 Jan 01; 91(2):537-47. PubMed ID: 10366011
    [Abstract] [Full Text] [Related]

  • 9. Effects of in utero cocaine exposure on the expression of mRNAS encoding the dopamine transporter and the D1, D2 and D5 dopamine receptor subtypes in fetal rhesus monkey.
    Choi WS, Rønnekleiv OK.
    Brain Res Dev Brain Res; 1996 Oct 23; 96(1-2):249-60. PubMed ID: 8922687
    [Abstract] [Full Text] [Related]

  • 10. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter.
    Fauchey V, Jaber M, Caron MG, Bloch B, Le Moine C.
    Eur J Neurosci; 2000 Jan 23; 12(1):19-26. PubMed ID: 10651856
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genetic and Functional Analysis of Polymorphisms in the Human Dopamine Receptor and Transporter Genes in Small Cell Lung Cancer.
    Cherubini E, Di Napoli A, Noto A, Osman GA, Esposito MC, Mariotta S, Sellitri R, Ruco L, Cardillo G, Ciliberto G, Mancini R, Ricci A.
    J Cell Physiol; 2016 Feb 23; 231(2):345-56. PubMed ID: 26081799
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 23; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 15. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H, Sato H, Ida I, Oshima A, Sakurai N, Shihara N, Horikawa Y, Mikuni M.
    Pharmacol Biochem Behav; 2007 May 23; 87(1):56-64. PubMed ID: 17499349
    [Abstract] [Full Text] [Related]

  • 16. Differential inhibition of secretagogue-stimulated sodium uptake in adrenal chromaffin cells by activation of D4 and D5 dopamine receptors.
    Dahmer MK, Senogles SE.
    J Neurochem; 1996 Nov 23; 67(5):1960-4. PubMed ID: 8863501
    [Abstract] [Full Text] [Related]

  • 17. Endogenous and exogenous dopamine depress EPSCs in rat nucleus accumbens in vitro via D1 receptors activation.
    Harvey J, Lacey MG.
    J Physiol; 1996 Apr 01; 492 ( Pt 1)(Pt 1):143-54. PubMed ID: 8730590
    [Abstract] [Full Text] [Related]

  • 18. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.
    Cho S, Neff NH, Hadjiconstantinou M.
    Eur J Pharmacol; 1997 Apr 04; 323(2-3):149-57. PubMed ID: 9128833
    [Abstract] [Full Text] [Related]

  • 19. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
    Momiyama T, Todo N, Sasa M.
    Br J Pharmacol; 1993 Aug 04; 109(4):933-40. PubMed ID: 8104652
    [Abstract] [Full Text] [Related]

  • 20. Distribution of dopamine D1, D2, and D5 receptor mRNAs in the monkey brain: ribonuclease protection assay analysis.
    Choi WS, Machida CA, Ronnekleiv OK.
    Brain Res Mol Brain Res; 1995 Jul 04; 31(1-2):86-94. PubMed ID: 7476036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.